Filing Details
- Accession Number:
- 0001144204-18-064217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-12 13:15:38
- Reporting Period:
- 2018-12-03
- Accepted Time:
- 2018-12-12 13:15:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1644963 | Avenue Therapeutics Inc. | ATXI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1595327 | Jeffrey Paley | C/O Avenue Therapeutics, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-12-03 | 10,000 | $5.48 | 74,663 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-12-10 | 5,000 | $4.76 | 79,663 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on December 3, 2018 was $5.4734 to $5.4774. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- Includes 64,663 shares of restricted stock.